Global Companion Diagnostic Market Research Report 2024, Forecast to 2032
Report Overview
A companion diagnostic device is a special type of invitro medical device that provides information, which is necessary for the effective and safe use of an analogous drug or biological product. Companion diagnostics are developed simultaneously with drugs to help include or exclude a certain group of patients for treatment with a particular drug based on their biological characteristics, which determines patients who respond and those who dont respond to the therapy.
The global Companion Diagnostic market size was estimated at USD 8820 million in 2023 and is projected to reach USD 46543.52 million by 2032, exhibiting a CAGR of 20.30% during the forecast period.
North America Companion Diagnostic market size was estimated at USD 3167.61 million in 2023, at a CAGR of 17.40% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Companion Diagnostic market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Companion Diagnostic Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Companion Diagnostic market in any manner.
Global Companion Diagnostic Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche Holdings
Abbott Laboratories
Thermo Fisher Scientific
Agilent Technologies
Merck
Agendia
Qiagen
Myriad Genetics
Advanced Cell Diagnostics
Danaher
Illumina
Inc
Market Segmentation (by Type)
Immunohistochemistry
Molecular Diagnosis
Market Segmentation (by Application)
Oncology
Cardiovascular
Central Nervous System
Virology
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Companion Diagnostic Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Companion Diagnostic, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
A companion diagnostic device is a special type of invitro medical device that provides information, which is necessary for the effective and safe use of an analogous drug or biological product. Companion diagnostics are developed simultaneously with drugs to help include or exclude a certain group of patients for treatment with a particular drug based on their biological characteristics, which determines patients who respond and those who dont respond to the therapy.
The global Companion Diagnostic market size was estimated at USD 8820 million in 2023 and is projected to reach USD 46543.52 million by 2032, exhibiting a CAGR of 20.30% during the forecast period.
North America Companion Diagnostic market size was estimated at USD 3167.61 million in 2023, at a CAGR of 17.40% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Companion Diagnostic market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Companion Diagnostic Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Companion Diagnostic market in any manner.
Global Companion Diagnostic Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche Holdings
Abbott Laboratories
Thermo Fisher Scientific
Agilent Technologies
Merck
Agendia
Qiagen
Myriad Genetics
Advanced Cell Diagnostics
Danaher
Illumina
Inc
Market Segmentation (by Type)
Immunohistochemistry
Molecular Diagnosis
Market Segmentation (by Application)
Oncology
Cardiovascular
Central Nervous System
Virology
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Companion Diagnostic Market
- Overview of the regional outlook of the Companion Diagnostic Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Companion Diagnostic Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Companion Diagnostic, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Companion Diagnostic
1.2 Key Market Segments
1.2.1 Companion Diagnostic Segment by Type
1.2.2 Companion Diagnostic Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 COMPANION DIAGNOSTIC MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Companion Diagnostic Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Companion Diagnostic Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 COMPANION DIAGNOSTIC MARKET COMPETITIVE LANDSCAPE
3.1 Global Companion Diagnostic Sales by Manufacturers (2019-2024)
3.2 Global Companion Diagnostic Revenue Market Share by Manufacturers (2019-2024)
3.3 Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Companion Diagnostic Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Companion Diagnostic Sales Sites, Area Served, Product Type
3.6 Companion Diagnostic Market Competitive Situation and Trends
3.6.1 Companion Diagnostic Market Concentration Rate
3.6.2 Global 5 and 10 Largest Companion Diagnostic Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 COMPANION DIAGNOSTIC INDUSTRY CHAIN ANALYSIS
4.1 Companion Diagnostic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF COMPANION DIAGNOSTIC MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 COMPANION DIAGNOSTIC MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Companion Diagnostic Sales Market Share by Type (2019-2024)
6.3 Global Companion Diagnostic Market Size Market Share by Type (2019-2024)
6.4 Global Companion Diagnostic Price by Type (2019-2024)
7 COMPANION DIAGNOSTIC MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Companion Diagnostic Market Sales by Application (2019-2024)
7.3 Global Companion Diagnostic Market Size (M USD) by Application (2019-2024)
7.4 Global Companion Diagnostic Sales Growth Rate by Application (2019-2024)
8 COMPANION DIAGNOSTIC MARKET CONSUMPTION BY REGION
8.1 Global Companion Diagnostic Sales by Region
8.1.1 Global Companion Diagnostic Sales by Region
8.1.2 Global Companion Diagnostic Sales Market Share by Region
8.2 North America
8.2.1 North America Companion Diagnostic Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Companion Diagnostic Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Companion Diagnostic Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Companion Diagnostic Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Companion Diagnostic Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 COMPANION DIAGNOSTIC MARKET PRODUCTION BY REGION
9.1 Global Production of Companion Diagnostic by Region (2019-2024)
9.2 Global Companion Diagnostic Revenue Market Share by Region (2019-2024)
9.3 Global Companion Diagnostic Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Companion Diagnostic Production
9.4.1 North America Companion Diagnostic Production Growth Rate (2019-2024)
9.4.2 North America Companion Diagnostic Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Companion Diagnostic Production
9.5.1 Europe Companion Diagnostic Production Growth Rate (2019-2024)
9.5.2 Europe Companion Diagnostic Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Companion Diagnostic Production (2019-2024)
9.6.1 Japan Companion Diagnostic Production Growth Rate (2019-2024)
9.6.2 Japan Companion Diagnostic Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Companion Diagnostic Production (2019-2024)
9.7.1 China Companion Diagnostic Production Growth Rate (2019-2024)
9.7.2 China Companion Diagnostic Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Roche Holdings
10.1.1 Roche Holdings Companion Diagnostic Basic Information
10.1.2 Roche Holdings Companion Diagnostic Product Overview
10.1.3 Roche Holdings Companion Diagnostic Product Market Performance
10.1.4 Roche Holdings Business Overview
10.1.5 Roche Holdings Companion Diagnostic SWOT Analysis
10.1.6 Roche Holdings Recent Developments
10.2 Abbott Laboratories
10.2.1 Abbott Laboratories Companion Diagnostic Basic Information
10.2.2 Abbott Laboratories Companion Diagnostic Product Overview
10.2.3 Abbott Laboratories Companion Diagnostic Product Market Performance
10.2.4 Abbott Laboratories Business Overview
10.2.5 Abbott Laboratories Companion Diagnostic SWOT Analysis
10.2.6 Abbott Laboratories Recent Developments
10.3 Thermo Fisher Scientific
10.3.1 Thermo Fisher Scientific Companion Diagnostic Basic Information
10.3.2 Thermo Fisher Scientific Companion Diagnostic Product Overview
10.3.3 Thermo Fisher Scientific Companion Diagnostic Product Market Performance
10.3.4 Thermo Fisher Scientific Companion Diagnostic SWOT Analysis
10.3.5 Thermo Fisher Scientific Business Overview
10.3.6 Thermo Fisher Scientific Recent Developments
10.4 Agilent Technologies
10.4.1 Agilent Technologies Companion Diagnostic Basic Information
10.4.2 Agilent Technologies Companion Diagnostic Product Overview
10.4.3 Agilent Technologies Companion Diagnostic Product Market Performance
10.4.4 Agilent Technologies Business Overview
10.4.5 Agilent Technologies Recent Developments
10.5 Merck
10.5.1 Merck Companion Diagnostic Basic Information
10.5.2 Merck Companion Diagnostic Product Overview
10.5.3 Merck Companion Diagnostic Product Market Performance
10.5.4 Merck Business Overview
10.5.5 Merck Recent Developments
10.6 Agendia
10.6.1 Agendia Companion Diagnostic Basic Information
10.6.2 Agendia Companion Diagnostic Product Overview
10.6.3 Agendia Companion Diagnostic Product Market Performance
10.6.4 Agendia Business Overview
10.6.5 Agendia Recent Developments
10.7 Qiagen
10.7.1 Qiagen Companion Diagnostic Basic Information
10.7.2 Qiagen Companion Diagnostic Product Overview
10.7.3 Qiagen Companion Diagnostic Product Market Performance
10.7.4 Qiagen Business Overview
10.7.5 Qiagen Recent Developments
10.8 Myriad Genetics
10.8.1 Myriad Genetics Companion Diagnostic Basic Information
10.8.2 Myriad Genetics Companion Diagnostic Product Overview
10.8.3 Myriad Genetics Companion Diagnostic Product Market Performance
10.8.4 Myriad Genetics Business Overview
10.8.5 Myriad Genetics Recent Developments
10.9 Advanced Cell Diagnostics
10.9.1 Advanced Cell Diagnostics Companion Diagnostic Basic Information
10.9.2 Advanced Cell Diagnostics Companion Diagnostic Product Overview
10.9.3 Advanced Cell Diagnostics Companion Diagnostic Product Market Performance
10.9.4 Advanced Cell Diagnostics Business Overview
10.9.5 Advanced Cell Diagnostics Recent Developments
10.10 Danaher
10.10.1 Danaher Companion Diagnostic Basic Information
10.10.2 Danaher Companion Diagnostic Product Overview
10.10.3 Danaher Companion Diagnostic Product Market Performance
10.10.4 Danaher Business Overview
10.10.5 Danaher Recent Developments
10.11 Illumina
10.11.1 Illumina Companion Diagnostic Basic Information
10.11.2 Illumina Companion Diagnostic Product Overview
10.11.3 Illumina Companion Diagnostic Product Market Performance
10.11.4 Illumina Business Overview
10.11.5 Illumina Recent Developments
10.12 Inc
10.12.1 Inc Companion Diagnostic Basic Information
10.12.2 Inc Companion Diagnostic Product Overview
10.12.3 Inc Companion Diagnostic Product Market Performance
10.12.4 Inc Business Overview
10.12.5 Inc Recent Developments
11 COMPANION DIAGNOSTIC MARKET FORECAST BY REGION
11.1 Global Companion Diagnostic Market Size Forecast
11.2 Global Companion Diagnostic Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Companion Diagnostic Market Size Forecast by Country
11.2.3 Asia Pacific Companion Diagnostic Market Size Forecast by Region
11.2.4 South America Companion Diagnostic Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Companion Diagnostic by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Companion Diagnostic Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Companion Diagnostic by Type (2025-2032)
12.1.2 Global Companion Diagnostic Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Companion Diagnostic by Type (2025-2032)
12.2 Global Companion Diagnostic Market Forecast by Application (2025-2032)
12.2.1 Global Companion Diagnostic Sales (K Units) Forecast by Application
12.2.2 Global Companion Diagnostic Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Companion Diagnostic
1.2 Key Market Segments
1.2.1 Companion Diagnostic Segment by Type
1.2.2 Companion Diagnostic Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 COMPANION DIAGNOSTIC MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Companion Diagnostic Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Companion Diagnostic Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 COMPANION DIAGNOSTIC MARKET COMPETITIVE LANDSCAPE
3.1 Global Companion Diagnostic Sales by Manufacturers (2019-2024)
3.2 Global Companion Diagnostic Revenue Market Share by Manufacturers (2019-2024)
3.3 Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Companion Diagnostic Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Companion Diagnostic Sales Sites, Area Served, Product Type
3.6 Companion Diagnostic Market Competitive Situation and Trends
3.6.1 Companion Diagnostic Market Concentration Rate
3.6.2 Global 5 and 10 Largest Companion Diagnostic Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 COMPANION DIAGNOSTIC INDUSTRY CHAIN ANALYSIS
4.1 Companion Diagnostic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF COMPANION DIAGNOSTIC MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 COMPANION DIAGNOSTIC MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Companion Diagnostic Sales Market Share by Type (2019-2024)
6.3 Global Companion Diagnostic Market Size Market Share by Type (2019-2024)
6.4 Global Companion Diagnostic Price by Type (2019-2024)
7 COMPANION DIAGNOSTIC MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Companion Diagnostic Market Sales by Application (2019-2024)
7.3 Global Companion Diagnostic Market Size (M USD) by Application (2019-2024)
7.4 Global Companion Diagnostic Sales Growth Rate by Application (2019-2024)
8 COMPANION DIAGNOSTIC MARKET CONSUMPTION BY REGION
8.1 Global Companion Diagnostic Sales by Region
8.1.1 Global Companion Diagnostic Sales by Region
8.1.2 Global Companion Diagnostic Sales Market Share by Region
8.2 North America
8.2.1 North America Companion Diagnostic Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Companion Diagnostic Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Companion Diagnostic Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Companion Diagnostic Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Companion Diagnostic Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 COMPANION DIAGNOSTIC MARKET PRODUCTION BY REGION
9.1 Global Production of Companion Diagnostic by Region (2019-2024)
9.2 Global Companion Diagnostic Revenue Market Share by Region (2019-2024)
9.3 Global Companion Diagnostic Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Companion Diagnostic Production
9.4.1 North America Companion Diagnostic Production Growth Rate (2019-2024)
9.4.2 North America Companion Diagnostic Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Companion Diagnostic Production
9.5.1 Europe Companion Diagnostic Production Growth Rate (2019-2024)
9.5.2 Europe Companion Diagnostic Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Companion Diagnostic Production (2019-2024)
9.6.1 Japan Companion Diagnostic Production Growth Rate (2019-2024)
9.6.2 Japan Companion Diagnostic Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Companion Diagnostic Production (2019-2024)
9.7.1 China Companion Diagnostic Production Growth Rate (2019-2024)
9.7.2 China Companion Diagnostic Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Roche Holdings
10.1.1 Roche Holdings Companion Diagnostic Basic Information
10.1.2 Roche Holdings Companion Diagnostic Product Overview
10.1.3 Roche Holdings Companion Diagnostic Product Market Performance
10.1.4 Roche Holdings Business Overview
10.1.5 Roche Holdings Companion Diagnostic SWOT Analysis
10.1.6 Roche Holdings Recent Developments
10.2 Abbott Laboratories
10.2.1 Abbott Laboratories Companion Diagnostic Basic Information
10.2.2 Abbott Laboratories Companion Diagnostic Product Overview
10.2.3 Abbott Laboratories Companion Diagnostic Product Market Performance
10.2.4 Abbott Laboratories Business Overview
10.2.5 Abbott Laboratories Companion Diagnostic SWOT Analysis
10.2.6 Abbott Laboratories Recent Developments
10.3 Thermo Fisher Scientific
10.3.1 Thermo Fisher Scientific Companion Diagnostic Basic Information
10.3.2 Thermo Fisher Scientific Companion Diagnostic Product Overview
10.3.3 Thermo Fisher Scientific Companion Diagnostic Product Market Performance
10.3.4 Thermo Fisher Scientific Companion Diagnostic SWOT Analysis
10.3.5 Thermo Fisher Scientific Business Overview
10.3.6 Thermo Fisher Scientific Recent Developments
10.4 Agilent Technologies
10.4.1 Agilent Technologies Companion Diagnostic Basic Information
10.4.2 Agilent Technologies Companion Diagnostic Product Overview
10.4.3 Agilent Technologies Companion Diagnostic Product Market Performance
10.4.4 Agilent Technologies Business Overview
10.4.5 Agilent Technologies Recent Developments
10.5 Merck
10.5.1 Merck Companion Diagnostic Basic Information
10.5.2 Merck Companion Diagnostic Product Overview
10.5.3 Merck Companion Diagnostic Product Market Performance
10.5.4 Merck Business Overview
10.5.5 Merck Recent Developments
10.6 Agendia
10.6.1 Agendia Companion Diagnostic Basic Information
10.6.2 Agendia Companion Diagnostic Product Overview
10.6.3 Agendia Companion Diagnostic Product Market Performance
10.6.4 Agendia Business Overview
10.6.5 Agendia Recent Developments
10.7 Qiagen
10.7.1 Qiagen Companion Diagnostic Basic Information
10.7.2 Qiagen Companion Diagnostic Product Overview
10.7.3 Qiagen Companion Diagnostic Product Market Performance
10.7.4 Qiagen Business Overview
10.7.5 Qiagen Recent Developments
10.8 Myriad Genetics
10.8.1 Myriad Genetics Companion Diagnostic Basic Information
10.8.2 Myriad Genetics Companion Diagnostic Product Overview
10.8.3 Myriad Genetics Companion Diagnostic Product Market Performance
10.8.4 Myriad Genetics Business Overview
10.8.5 Myriad Genetics Recent Developments
10.9 Advanced Cell Diagnostics
10.9.1 Advanced Cell Diagnostics Companion Diagnostic Basic Information
10.9.2 Advanced Cell Diagnostics Companion Diagnostic Product Overview
10.9.3 Advanced Cell Diagnostics Companion Diagnostic Product Market Performance
10.9.4 Advanced Cell Diagnostics Business Overview
10.9.5 Advanced Cell Diagnostics Recent Developments
10.10 Danaher
10.10.1 Danaher Companion Diagnostic Basic Information
10.10.2 Danaher Companion Diagnostic Product Overview
10.10.3 Danaher Companion Diagnostic Product Market Performance
10.10.4 Danaher Business Overview
10.10.5 Danaher Recent Developments
10.11 Illumina
10.11.1 Illumina Companion Diagnostic Basic Information
10.11.2 Illumina Companion Diagnostic Product Overview
10.11.3 Illumina Companion Diagnostic Product Market Performance
10.11.4 Illumina Business Overview
10.11.5 Illumina Recent Developments
10.12 Inc
10.12.1 Inc Companion Diagnostic Basic Information
10.12.2 Inc Companion Diagnostic Product Overview
10.12.3 Inc Companion Diagnostic Product Market Performance
10.12.4 Inc Business Overview
10.12.5 Inc Recent Developments
11 COMPANION DIAGNOSTIC MARKET FORECAST BY REGION
11.1 Global Companion Diagnostic Market Size Forecast
11.2 Global Companion Diagnostic Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Companion Diagnostic Market Size Forecast by Country
11.2.3 Asia Pacific Companion Diagnostic Market Size Forecast by Region
11.2.4 South America Companion Diagnostic Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Companion Diagnostic by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Companion Diagnostic Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Companion Diagnostic by Type (2025-2032)
12.1.2 Global Companion Diagnostic Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Companion Diagnostic by Type (2025-2032)
12.2 Global Companion Diagnostic Market Forecast by Application (2025-2032)
12.2.1 Global Companion Diagnostic Sales (K Units) Forecast by Application
12.2.2 Global Companion Diagnostic Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Companion Diagnostic Market Size Comparison by Region (M USD)
Table 5. Global Companion Diagnostic Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Companion Diagnostic Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Companion Diagnostic Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Companion Diagnostic Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic as of 2022)
Table 10. Global Market Companion Diagnostic Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Companion Diagnostic Sales Sites and Area Served
Table 12. Manufacturers Companion Diagnostic Product Type
Table 13. Global Companion Diagnostic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Companion Diagnostic
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Companion Diagnostic Market Challenges
Table 22. Global Companion Diagnostic Sales by Type (K Units)
Table 23. Global Companion Diagnostic Market Size by Type (M USD)
Table 24. Global Companion Diagnostic Sales (K Units) by Type (2019-2024)
Table 25. Global Companion Diagnostic Sales Market Share by Type (2019-2024)
Table 26. Global Companion Diagnostic Market Size (M USD) by Type (2019-2024)
Table 27. Global Companion Diagnostic Market Size Share by Type (2019-2024)
Table 28. Global Companion Diagnostic Price (USD/Unit) by Type (2019-2024)
Table 29. Global Companion Diagnostic Sales (K Units) by Application
Table 30. Global Companion Diagnostic Market Size by Application
Table 31. Global Companion Diagnostic Sales by Application (2019-2024) & (K Units)
Table 32. Global Companion Diagnostic Sales Market Share by Application (2019-2024)
Table 33. Global Companion Diagnostic Sales by Application (2019-2024) & (M USD)
Table 34. Global Companion Diagnostic Market Share by Application (2019-2024)
Table 35. Global Companion Diagnostic Sales Growth Rate by Application (2019-2024)
Table 36. Global Companion Diagnostic Sales by Region (2019-2024) & (K Units)
Table 37. Global Companion Diagnostic Sales Market Share by Region (2019-2024)
Table 38. North America Companion Diagnostic Sales by Country (2019-2024) & (K Units)
Table 39. Europe Companion Diagnostic Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Companion Diagnostic Sales by Region (2019-2024) & (K Units)
Table 41. South America Companion Diagnostic Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Companion Diagnostic Sales by Region (2019-2024) & (K Units)
Table 43. Global Companion Diagnostic Production (K Units) by Region (2019-2024)
Table 44. Global Companion Diagnostic Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Companion Diagnostic Revenue Market Share by Region (2019-2024)
Table 46. Global Companion Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 47. North America Companion Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Europe Companion Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Japan Companion Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 50. China Companion Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 51. Roche Holdings Companion Diagnostic Basic Information
Table 52. Roche Holdings Companion Diagnostic Product Overview
Table 53. Roche Holdings Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 54. Roche Holdings Business Overview
Table 55. Roche Holdings Companion Diagnostic SWOT Analysis
Table 56. Roche Holdings Recent Developments
Table 57. Abbott Laboratories Companion Diagnostic Basic Information
Table 58. Abbott Laboratories Companion Diagnostic Product Overview
Table 59. Abbott Laboratories Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Abbott Laboratories Business Overview
Table 61. Abbott Laboratories Companion Diagnostic SWOT Analysis
Table 62. Abbott Laboratories Recent Developments
Table 63. Thermo Fisher Scientific Companion Diagnostic Basic Information
Table 64. Thermo Fisher Scientific Companion Diagnostic Product Overview
Table 65. Thermo Fisher Scientific Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 66. Thermo Fisher Scientific Companion Diagnostic SWOT Analysis
Table 67. Thermo Fisher Scientific Business Overview
Table 68. Thermo Fisher Scientific Recent Developments
Table 69. Agilent Technologies Companion Diagnostic Basic Information
Table 70. Agilent Technologies Companion Diagnostic Product Overview
Table 71. Agilent Technologies Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. Agilent Technologies Business Overview
Table 73. Agilent Technologies Recent Developments
Table 74. Merck Companion Diagnostic Basic Information
Table 75. Merck Companion Diagnostic Product Overview
Table 76. Merck Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Merck Business Overview
Table 78. Merck Recent Developments
Table 79. Agendia Companion Diagnostic Basic Information
Table 80. Agendia Companion Diagnostic Product Overview
Table 81. Agendia Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Agendia Business Overview
Table 83. Agendia Recent Developments
Table 84. Qiagen Companion Diagnostic Basic Information
Table 85. Qiagen Companion Diagnostic Product Overview
Table 86. Qiagen Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Qiagen Business Overview
Table 88. Qiagen Recent Developments
Table 89. Myriad Genetics Companion Diagnostic Basic Information
Table 90. Myriad Genetics Companion Diagnostic Product Overview
Table 91. Myriad Genetics Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Myriad Genetics Business Overview
Table 93. Myriad Genetics Recent Developments
Table 94. Advanced Cell Diagnostics Companion Diagnostic Basic Information
Table 95. Advanced Cell Diagnostics Companion Diagnostic Product Overview
Table 96. Advanced Cell Diagnostics Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Advanced Cell Diagnostics Business Overview
Table 98. Advanced Cell Diagnostics Recent Developments
Table 99. Danaher Companion Diagnostic Basic Information
Table 100. Danaher Companion Diagnostic Product Overview
Table 101. Danaher Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Danaher Business Overview
Table 103. Danaher Recent Developments
Table 104. Illumina Companion Diagnostic Basic Information
Table 105. Illumina Companion Diagnostic Product Overview
Table 106. Illumina Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Illumina Business Overview
Table 108. Illumina Recent Developments
Table 109. Inc Companion Diagnostic Basic Information
Table 110. Inc Companion Diagnostic Product Overview
Table 111. Inc Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Inc Business Overview
Table 113. Inc Recent Developments
Table 114. Global Companion Diagnostic Sales Forecast by Region (2025-2032) & (K Units)
Table 115. Global Companion Diagnostic Market Size Forecast by Region (2025-2032) & (M USD)
Table 116. North America Companion Diagnostic Sales Forecast by Country (2025-2032) & (K Units)
Table 117. North America Companion Diagnostic Market Size Forecast by Country (2025-2032) & (M USD)
Table 118. Europe Companion Diagnostic Sales Forecast by Country (2025-2032) & (K Units)
Table 119. Europe Companion Diagnostic Market Size Forecast by Country (2025-2032) & (M USD)
Table 120. Asia Pacific Companion Diagnostic Sales Forecast by Region (2025-2032) & (K Units)
Table 121. Asia Pacific Companion Diagnostic Market Size Forecast by Region (2025-2032) & (M USD)
Table 122. South America Companion Diagnostic Sales Forecast by Country (2025-2032) & (K Units)
Table 123. South America Companion Diagnostic Market Size Forecast by Country (2025-2032) & (M USD)
Table 124. Middle East and Africa Companion Diagnostic Consumption Forecast by Country (2025-2032) & (Units)
Table 125. Middle East and Africa Companion Diagnostic Market Size Forecast by Country (2025-2032) & (M USD)
Table 126. Global Companion Diagnostic Sales Forecast by Type (2025-2032) & (K Units)
Table 127. Global Companion Diagnostic Market Size Forecast by Type (2025-2032) & (M USD)
Table 128. Global Companion Diagnostic Price Forecast by Type (2025-2032) & (USD/Unit)
Table 129. Global Companion Diagnostic Sales (K Units) Forecast by Application (2025-2032)
Table 130. Global Companion Diagnostic Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Companion Diagnostic Market Size Comparison by Region (M USD)
Table 5. Global Companion Diagnostic Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Companion Diagnostic Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Companion Diagnostic Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Companion Diagnostic Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic as of 2022)
Table 10. Global Market Companion Diagnostic Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Companion Diagnostic Sales Sites and Area Served
Table 12. Manufacturers Companion Diagnostic Product Type
Table 13. Global Companion Diagnostic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Companion Diagnostic
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Companion Diagnostic Market Challenges
Table 22. Global Companion Diagnostic Sales by Type (K Units)
Table 23. Global Companion Diagnostic Market Size by Type (M USD)
Table 24. Global Companion Diagnostic Sales (K Units) by Type (2019-2024)
Table 25. Global Companion Diagnostic Sales Market Share by Type (2019-2024)
Table 26. Global Companion Diagnostic Market Size (M USD) by Type (2019-2024)
Table 27. Global Companion Diagnostic Market Size Share by Type (2019-2024)
Table 28. Global Companion Diagnostic Price (USD/Unit) by Type (2019-2024)
Table 29. Global Companion Diagnostic Sales (K Units) by Application
Table 30. Global Companion Diagnostic Market Size by Application
Table 31. Global Companion Diagnostic Sales by Application (2019-2024) & (K Units)
Table 32. Global Companion Diagnostic Sales Market Share by Application (2019-2024)
Table 33. Global Companion Diagnostic Sales by Application (2019-2024) & (M USD)
Table 34. Global Companion Diagnostic Market Share by Application (2019-2024)
Table 35. Global Companion Diagnostic Sales Growth Rate by Application (2019-2024)
Table 36. Global Companion Diagnostic Sales by Region (2019-2024) & (K Units)
Table 37. Global Companion Diagnostic Sales Market Share by Region (2019-2024)
Table 38. North America Companion Diagnostic Sales by Country (2019-2024) & (K Units)
Table 39. Europe Companion Diagnostic Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Companion Diagnostic Sales by Region (2019-2024) & (K Units)
Table 41. South America Companion Diagnostic Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Companion Diagnostic Sales by Region (2019-2024) & (K Units)
Table 43. Global Companion Diagnostic Production (K Units) by Region (2019-2024)
Table 44. Global Companion Diagnostic Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Companion Diagnostic Revenue Market Share by Region (2019-2024)
Table 46. Global Companion Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 47. North America Companion Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Europe Companion Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Japan Companion Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 50. China Companion Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 51. Roche Holdings Companion Diagnostic Basic Information
Table 52. Roche Holdings Companion Diagnostic Product Overview
Table 53. Roche Holdings Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 54. Roche Holdings Business Overview
Table 55. Roche Holdings Companion Diagnostic SWOT Analysis
Table 56. Roche Holdings Recent Developments
Table 57. Abbott Laboratories Companion Diagnostic Basic Information
Table 58. Abbott Laboratories Companion Diagnostic Product Overview
Table 59. Abbott Laboratories Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Abbott Laboratories Business Overview
Table 61. Abbott Laboratories Companion Diagnostic SWOT Analysis
Table 62. Abbott Laboratories Recent Developments
Table 63. Thermo Fisher Scientific Companion Diagnostic Basic Information
Table 64. Thermo Fisher Scientific Companion Diagnostic Product Overview
Table 65. Thermo Fisher Scientific Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 66. Thermo Fisher Scientific Companion Diagnostic SWOT Analysis
Table 67. Thermo Fisher Scientific Business Overview
Table 68. Thermo Fisher Scientific Recent Developments
Table 69. Agilent Technologies Companion Diagnostic Basic Information
Table 70. Agilent Technologies Companion Diagnostic Product Overview
Table 71. Agilent Technologies Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. Agilent Technologies Business Overview
Table 73. Agilent Technologies Recent Developments
Table 74. Merck Companion Diagnostic Basic Information
Table 75. Merck Companion Diagnostic Product Overview
Table 76. Merck Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Merck Business Overview
Table 78. Merck Recent Developments
Table 79. Agendia Companion Diagnostic Basic Information
Table 80. Agendia Companion Diagnostic Product Overview
Table 81. Agendia Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Agendia Business Overview
Table 83. Agendia Recent Developments
Table 84. Qiagen Companion Diagnostic Basic Information
Table 85. Qiagen Companion Diagnostic Product Overview
Table 86. Qiagen Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Qiagen Business Overview
Table 88. Qiagen Recent Developments
Table 89. Myriad Genetics Companion Diagnostic Basic Information
Table 90. Myriad Genetics Companion Diagnostic Product Overview
Table 91. Myriad Genetics Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Myriad Genetics Business Overview
Table 93. Myriad Genetics Recent Developments
Table 94. Advanced Cell Diagnostics Companion Diagnostic Basic Information
Table 95. Advanced Cell Diagnostics Companion Diagnostic Product Overview
Table 96. Advanced Cell Diagnostics Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Advanced Cell Diagnostics Business Overview
Table 98. Advanced Cell Diagnostics Recent Developments
Table 99. Danaher Companion Diagnostic Basic Information
Table 100. Danaher Companion Diagnostic Product Overview
Table 101. Danaher Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Danaher Business Overview
Table 103. Danaher Recent Developments
Table 104. Illumina Companion Diagnostic Basic Information
Table 105. Illumina Companion Diagnostic Product Overview
Table 106. Illumina Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Illumina Business Overview
Table 108. Illumina Recent Developments
Table 109. Inc Companion Diagnostic Basic Information
Table 110. Inc Companion Diagnostic Product Overview
Table 111. Inc Companion Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Inc Business Overview
Table 113. Inc Recent Developments
Table 114. Global Companion Diagnostic Sales Forecast by Region (2025-2032) & (K Units)
Table 115. Global Companion Diagnostic Market Size Forecast by Region (2025-2032) & (M USD)
Table 116. North America Companion Diagnostic Sales Forecast by Country (2025-2032) & (K Units)
Table 117. North America Companion Diagnostic Market Size Forecast by Country (2025-2032) & (M USD)
Table 118. Europe Companion Diagnostic Sales Forecast by Country (2025-2032) & (K Units)
Table 119. Europe Companion Diagnostic Market Size Forecast by Country (2025-2032) & (M USD)
Table 120. Asia Pacific Companion Diagnostic Sales Forecast by Region (2025-2032) & (K Units)
Table 121. Asia Pacific Companion Diagnostic Market Size Forecast by Region (2025-2032) & (M USD)
Table 122. South America Companion Diagnostic Sales Forecast by Country (2025-2032) & (K Units)
Table 123. South America Companion Diagnostic Market Size Forecast by Country (2025-2032) & (M USD)
Table 124. Middle East and Africa Companion Diagnostic Consumption Forecast by Country (2025-2032) & (Units)
Table 125. Middle East and Africa Companion Diagnostic Market Size Forecast by Country (2025-2032) & (M USD)
Table 126. Global Companion Diagnostic Sales Forecast by Type (2025-2032) & (K Units)
Table 127. Global Companion Diagnostic Market Size Forecast by Type (2025-2032) & (M USD)
Table 128. Global Companion Diagnostic Price Forecast by Type (2025-2032) & (USD/Unit)
Table 129. Global Companion Diagnostic Sales (K Units) Forecast by Application (2025-2032)
Table 130. Global Companion Diagnostic Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Companion Diagnostic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Companion Diagnostic Market Size (M USD), 2019-2032
Figure 5. Global Companion Diagnostic Market Size (M USD) (2019-2032)
Figure 6. Global Companion Diagnostic Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Companion Diagnostic Market Size by Country (M USD)
Figure 11. Companion Diagnostic Sales Share by Manufacturers in 2023
Figure 12. Global Companion Diagnostic Revenue Share by Manufacturers in 2023
Figure 13. Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Companion Diagnostic Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Companion Diagnostic Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Companion Diagnostic Market Share by Type
Figure 18. Sales Market Share of Companion Diagnostic by Type (2019-2024)
Figure 19. Sales Market Share of Companion Diagnostic by Type in 2023
Figure 20. Market Size Share of Companion Diagnostic by Type (2019-2024)
Figure 21. Market Size Market Share of Companion Diagnostic by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Companion Diagnostic Market Share by Application
Figure 24. Global Companion Diagnostic Sales Market Share by Application (2019-2024)
Figure 25. Global Companion Diagnostic Sales Market Share by Application in 2023
Figure 26. Global Companion Diagnostic Market Share by Application (2019-2024)
Figure 27. Global Companion Diagnostic Market Share by Application in 2023
Figure 28. Global Companion Diagnostic Sales Growth Rate by Application (2019-2024)
Figure 29. Global Companion Diagnostic Sales Market Share by Region (2019-2024)
Figure 30. North America Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Companion Diagnostic Sales Market Share by Country in 2023
Figure 32. U.S. Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Companion Diagnostic Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Companion Diagnostic Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Companion Diagnostic Sales Market Share by Country in 2023
Figure 37. Germany Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Companion Diagnostic Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Companion Diagnostic Sales Market Share by Region in 2023
Figure 44. China Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Companion Diagnostic Sales and Growth Rate (K Units)
Figure 50. South America Companion Diagnostic Sales Market Share by Country in 2023
Figure 51. Brazil Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Companion Diagnostic Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Companion Diagnostic Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Companion Diagnostic Production Market Share by Region (2019-2024)
Figure 62. North America Companion Diagnostic Production (K Units) Growth Rate (2019-2024)
Figure 63. Europe Companion Diagnostic Production (K Units) Growth Rate (2019-2024)
Figure 64. Japan Companion Diagnostic Production (K Units) Growth Rate (2019-2024)
Figure 65. China Companion Diagnostic Production (K Units) Growth Rate (2019-2024)
Figure 66. Global Companion Diagnostic Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Companion Diagnostic Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Companion Diagnostic Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Companion Diagnostic Market Share Forecast by Type (2025-2032)
Figure 70. Global Companion Diagnostic Sales Forecast by Application (2025-2032)
Figure 71. Global Companion Diagnostic Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Companion Diagnostic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Companion Diagnostic Market Size (M USD), 2019-2032
Figure 5. Global Companion Diagnostic Market Size (M USD) (2019-2032)
Figure 6. Global Companion Diagnostic Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Companion Diagnostic Market Size by Country (M USD)
Figure 11. Companion Diagnostic Sales Share by Manufacturers in 2023
Figure 12. Global Companion Diagnostic Revenue Share by Manufacturers in 2023
Figure 13. Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Companion Diagnostic Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Companion Diagnostic Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Companion Diagnostic Market Share by Type
Figure 18. Sales Market Share of Companion Diagnostic by Type (2019-2024)
Figure 19. Sales Market Share of Companion Diagnostic by Type in 2023
Figure 20. Market Size Share of Companion Diagnostic by Type (2019-2024)
Figure 21. Market Size Market Share of Companion Diagnostic by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Companion Diagnostic Market Share by Application
Figure 24. Global Companion Diagnostic Sales Market Share by Application (2019-2024)
Figure 25. Global Companion Diagnostic Sales Market Share by Application in 2023
Figure 26. Global Companion Diagnostic Market Share by Application (2019-2024)
Figure 27. Global Companion Diagnostic Market Share by Application in 2023
Figure 28. Global Companion Diagnostic Sales Growth Rate by Application (2019-2024)
Figure 29. Global Companion Diagnostic Sales Market Share by Region (2019-2024)
Figure 30. North America Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Companion Diagnostic Sales Market Share by Country in 2023
Figure 32. U.S. Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Companion Diagnostic Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Companion Diagnostic Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Companion Diagnostic Sales Market Share by Country in 2023
Figure 37. Germany Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Companion Diagnostic Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Companion Diagnostic Sales Market Share by Region in 2023
Figure 44. China Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Companion Diagnostic Sales and Growth Rate (K Units)
Figure 50. South America Companion Diagnostic Sales Market Share by Country in 2023
Figure 51. Brazil Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Companion Diagnostic Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Companion Diagnostic Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Companion Diagnostic Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Companion Diagnostic Production Market Share by Region (2019-2024)
Figure 62. North America Companion Diagnostic Production (K Units) Growth Rate (2019-2024)
Figure 63. Europe Companion Diagnostic Production (K Units) Growth Rate (2019-2024)
Figure 64. Japan Companion Diagnostic Production (K Units) Growth Rate (2019-2024)
Figure 65. China Companion Diagnostic Production (K Units) Growth Rate (2019-2024)
Figure 66. Global Companion Diagnostic Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Companion Diagnostic Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Companion Diagnostic Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Companion Diagnostic Market Share Forecast by Type (2025-2032)
Figure 70. Global Companion Diagnostic Sales Forecast by Application (2025-2032)
Figure 71. Global Companion Diagnostic Market Share Forecast by Application (2025-2032)
